The current weakness in Singapore’s exports is likely to extend into the first half of 2021, following a weakening of global demand over the same period says RHB’s Singapore research team in a report dated Dec 21.
However, the team also sees that exports from the pharmaceutical sector could remain “resilient” based on its in-house assumption of a gradual global roll-out of the Covid-19 vaccine in 2021, says the team.
